Literature DB >> 22426834

Where does a migraine attack originate? In the brainstem.

J Tajti1, D Szok, Á Párdutz, B Tuka, A Csáti, A Kuris, J Toldi, L Vécsei.   

Abstract

Migraine is a common, paroxysmal, highly disabling primary headache disorder. The origin of migraine attacks is enigmatic. Numerous clinical and experimental results suggest that the activation of distinct brainstem nuclei is crucial in its pathogenesis, but the primary cause of this activation is not fully understood. We conclude that the initialization of a migraine attack can be explained as an altered function of the neuronal elements of the brainstem nuclei. In light of our findings and the literature data, we can assume that migraine is a subcortical disorder of a specific brainstem area. © Springer-Verlag 2011

Entities:  

Mesh:

Year:  2012        PMID: 22426834     DOI: 10.1007/s00702-012-0788-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  169 in total

Review 1.  Acute migraine therapy: the newer drugs.

Authors:  J Schoenen
Journal:  Curr Opin Neurol       Date:  1997-06       Impact factor: 5.710

2.  Spreading depression in the brainstem of the adult rat: electrophysiological parameters and influences on regional brainstem blood flow.

Authors:  Frank Richter; Reinhard Bauer; Alfred Lehmenkühler; Hans-Georg Schaible
Journal:  J Cereb Blood Flow Metab       Date:  2007-12-05       Impact factor: 6.200

3.  Modulation of trigeminal reflex excitability in migraine: effects of attention and habituation on the blink reflex.

Authors:  Marina de Tommaso; Donatella Murasecco; Giuseppe Libro; Marco Guido; Vittorio Sciruicchio; Luigi Maria Specchio; Virgilio Gallai; Francomichele Puca
Journal:  Int J Psychophysiol       Date:  2002-06       Impact factor: 2.997

4.  Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

Authors:  R B Lipton; W F Stewart; S Diamond; M L Diamond; M Reed
Journal:  Headache       Date:  2001 Jul-Aug       Impact factor: 5.887

5.  5-HT-Immunoreactive fibers in the trigeminal nuclear complex of the rat.

Authors:  E C Cropper; J S Eisenman; E C Azmitia
Journal:  Exp Brain Res       Date:  1984       Impact factor: 1.972

6.  IFN-beta1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment.

Authors:  G J Guillemin; S J Kerr; L A Pemberton; D G Smith; G A Smythe; P J Armati; B J Brew
Journal:  J Interferon Cytokine Res       Date:  2001-12       Impact factor: 2.607

7.  The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.

Authors:  C Hilmas; E F Pereira; M Alkondon; A Rassoulpour; R Schwarcz; E X Albuquerque
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

8.  Neurochemical afferents controlling the activity of serotonergic neurons in the dorsal raphe nucleus: microiontophoretic studies in the awake cat.

Authors:  E S Levine; B L Jacobs
Journal:  J Neurosci       Date:  1992-10       Impact factor: 6.167

9.  Functional MRI-BOLD of brainstem structures during visually triggered migraine.

Authors:  Y Cao; S K Aurora; V Nagesh; S C Patel; K M A Welch
Journal:  Neurology       Date:  2002-07-09       Impact factor: 9.910

10.  MRI of the occipital cortex, red nucleus, and substantia nigra during visual aura of migraine.

Authors:  K M Welch; Y Cao; S Aurora; G Wiggins; E M Vikingstad
Journal:  Neurology       Date:  1998-11       Impact factor: 9.910

View more
  8 in total

1.  Systematic review of the pharmacological agents that have been tested against spreading depolarizations.

Authors:  Anna Klass; Renan Sánchez-Porras; Edgar Santos
Journal:  J Cereb Blood Flow Metab       Date:  2018-04-20       Impact factor: 6.200

Review 2.  Fathoming the kynurenine pathway in migraine: why understanding the enzymatic cascades is still critically important.

Authors:  Martina Curto; Luana Lionetto; Francesco Fazio; Dimos-Dimitrios Mitsikostas; Paolo Martelletti
Journal:  Intern Emerg Med       Date:  2015-02-24       Impact factor: 3.397

3.  Changes in Brainstem Pain Modulation Circuitry Function over the Migraine Cycle.

Authors:  Kasia K Marciszewski; Noemi Meylakh; Flavia Di Pietro; Emily P Mills; Vaughan G Macefield; Paul M Macey; Luke A Henderson
Journal:  J Neurosci       Date:  2018-10-19       Impact factor: 6.167

4.  Kynurenines and other novel therapeutic strategies in the treatment of dementia.

Authors:  Zsófia Majláth; János Tajti; László Vécsei
Journal:  Ther Adv Neurol Disord       Date:  2013-11       Impact factor: 6.570

Review 5.  Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety.

Authors:  Délia Szok; Anett Csáti; László Vécsei; János Tajti
Journal:  Toxins (Basel)       Date:  2015-07-17       Impact factor: 4.546

6.  When light hurts: Comparative Morphometry of Human Brainstem in Traumatic Photalgia.

Authors:  Lora T Likova; Christopher W Tyler
Journal:  Sci Rep       Date:  2018-04-19       Impact factor: 4.379

7.  Dynamic sodium imaging at ultra-high field reveals progression in a preclinical migraine model.

Authors:  Nastaren Abad; Jens T Rosenberg; David C Hike; Michael G Harrington; Samuel C Grant
Journal:  Pain       Date:  2018-10       Impact factor: 7.926

8.  Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood-brain barrier permeability.

Authors:  Gáspár Oláh; Judit Herédi; Akos Menyhárt; Zsolt Czinege; Dávid Nagy; János Fuzik; Kitti Kocsis; Levente Knapp; Erika Krucsó; Levente Gellért; Zsolt Kis; Tamás Farkas; Ferenc Fülöp; Arpád Párdutz; János Tajti; László Vécsei; József Toldi
Journal:  Drug Des Devel Ther       Date:  2013-09-16       Impact factor: 4.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.